E Capello

Summary

Affiliation: University of Genoa
Country: Italy

Publications

  1. ncbi Marburg type and Balò's concentric sclerosis: rare and acute variants of multiple sclerosis
    E Capello
    Deparment of Neuroscience, Oftalmology and Genetics, University of Genoa, Via De Toni 5, I 16132 Genoa, Italy
    Neurol Sci 25:S361-3. 2004
  2. ncbi Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis
    E Capello
    Department of Neurological Sciences Ophthalmology and Genetics, University of Genoa, Via De Toni 5, I 16132, Genoa, Italy
    Neurol Sci 26:S200-3. 2005
  3. ncbi Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience
    G L Mancardi
    Department of Neuroscience, Ophthalmology and Genetics, University of Genoa, Genoa, Italy
    Mult Scler 18:835-42. 2012
  4. ncbi Acute axonal form of Guillain-Barré syndrome in a multiple sclerosis patient: chance association or linked disorders?
    E Capello
    Department of Neurological Sciences and Vision, University of Genoa, Genoa, Italy
    Eur J Neurol 7:223-5. 2000
  5. ncbi Demyelination and axonal damage in a non-human primate model of multiple sclerosis
    G Mancardi
    Department of Neurological Sciences and Vision, University of Genoa, Via De Toni 5, 16132 Genoa, Italy
    J Neurol Sci 184:41-9. 2001
  6. ncbi Restricted immune responses lead to CNS demyelination and axonal damage
    G Mancardi
    Department of Neurological Sciences and Vision, University of Genova, Via De Toni 5, 16132, Genoa, Italy
    J Neuroimmunol 107:178-83. 2000
  7. ncbi Autologous haematopoietic stem-cell transplantation in multiple sclerosis: benefits and risks
    E Capello
    Department of Neuroscience, Ophthalmology and Genetics, University of Genova, Genoa, Italy
    Neurol Sci 30:S175-7. 2009
  8. ncbi Tumor-like multiple sclerosis (MS) lesions: neuropathological clues
    E Capello
    Department of Neurological Sciences and Vision, University of Genoa, Italy
    Neurol Sci 22:S113-6. 2001
  9. ncbi Association of melanoma and natalizumab therapy in the Italian MS population: a second case report
    A Laroni
    Multiple Sclerosis Center, Department of Neurosciences, Ophthalmology and Genetics, University of Genoa, Genoa, Italy
    Neurol Sci 32:181-2. 2011
  10. ncbi Urinary JCV-DNA testing during natalizumab treatment may increase accuracy of PML risk stratification
    A Laroni
    Department of Neuroscience, Ophthalmology and Genetics, University of Genova, Via De Toni 5, 16132, Genoa, Italy
    J Neuroimmune Pharmacol 7:665-72. 2012

Collaborators

Detail Information

Publications16

  1. ncbi Marburg type and Balò's concentric sclerosis: rare and acute variants of multiple sclerosis
    E Capello
    Deparment of Neuroscience, Oftalmology and Genetics, University of Genoa, Via De Toni 5, I 16132 Genoa, Italy
    Neurol Sci 25:S361-3. 2004
    ..Although in some patients a favourable clinical course has been described, the poor prognosis of the majority of these cases justifies a treatment with intense immunosuppression...
  2. ncbi Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis
    E Capello
    Department of Neurological Sciences Ophthalmology and Genetics, University of Genoa, Via De Toni 5, I 16132, Genoa, Italy
    Neurol Sci 26:S200-3. 2005
    ..These results support a role for intense immunosuppression followed by ASCT as treatment in rapidly evolving MS cases unresponsive to conventional therapies...
  3. ncbi Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience
    G L Mancardi
    Department of Neuroscience, Ophthalmology and Genetics, University of Genoa, Genoa, Italy
    Mult Scler 18:835-42. 2012
    ..The clinical outcome and the toxicity of AHSCT can be diverse, depending on the various types of conditioning protocols and on the disease phase...
  4. ncbi Acute axonal form of Guillain-Barré syndrome in a multiple sclerosis patient: chance association or linked disorders?
    E Capello
    Department of Neurological Sciences and Vision, University of Genoa, Genoa, Italy
    Eur J Neurol 7:223-5. 2000
    ..It remains unresolved if the association of an axonal form of GBS and MS is fortuitous or, on the contrary, is indicative of the coexistence in some individuals of common pathogenetic mechanisms...
  5. ncbi Demyelination and axonal damage in a non-human primate model of multiple sclerosis
    G Mancardi
    Department of Neurological Sciences and Vision, University of Genoa, Via De Toni 5, 16132 Genoa, Italy
    J Neurol Sci 184:41-9. 2001
    ..These findings are of relevance for the development of therapies, which can protect axons and enhance their function and survival...
  6. ncbi Restricted immune responses lead to CNS demyelination and axonal damage
    G Mancardi
    Department of Neurological Sciences and Vision, University of Genova, Via De Toni 5, 16132, Genoa, Italy
    J Neuroimmunol 107:178-83. 2000
    ....
  7. ncbi Autologous haematopoietic stem-cell transplantation in multiple sclerosis: benefits and risks
    E Capello
    Department of Neuroscience, Ophthalmology and Genetics, University of Genova, Genoa, Italy
    Neurol Sci 30:S175-7. 2009
    ..The risk of mortality, which dropped in the last years to 2-3%, is still the main problem of this powerful therapy...
  8. ncbi Tumor-like multiple sclerosis (MS) lesions: neuropathological clues
    E Capello
    Department of Neurological Sciences and Vision, University of Genoa, Italy
    Neurol Sci 22:S113-6. 2001
    ..These cases are characterized by a severe clinical course and a rapid clinical deterioration, only partially modified by medical treatments. Atypical severe cases, misdiagnosed as MS, can be indeed due to primary CNS vasculitis...
  9. ncbi Association of melanoma and natalizumab therapy in the Italian MS population: a second case report
    A Laroni
    Multiple Sclerosis Center, Department of Neurosciences, Ophthalmology and Genetics, University of Genoa, Genoa, Italy
    Neurol Sci 32:181-2. 2011
    ..Here we report a case of melanoma in a patient who developed melanoma after 77 infusions of natalizumab, without known risk factors. Pharmacovigilance programs of new drugs can help to monitor adverse events in patients at risk...
  10. ncbi Urinary JCV-DNA testing during natalizumab treatment may increase accuracy of PML risk stratification
    A Laroni
    Department of Neuroscience, Ophthalmology and Genetics, University of Genova, Via De Toni 5, 16132, Genoa, Italy
    J Neuroimmune Pharmacol 7:665-72. 2012
    ..In conclusion, testing JCV-DNA in urine is complementary to testing anti-JCV antibodies in identifying patients at risk of PML...
  11. ncbi EAE in the common marmoset Callithrix jacchus
    A Uccelli
    Neuroimmunology Unit, Department of Neurosciences, Ophthalmology and Genetics and Centre of Excellence for Biomedical Research, University of Genoa, Genoa, Italy
    Int MS J 10:6-12. 2003
    ....
  12. ncbi Tremor associated with benign IgM paraproteinaemic neuropathy successfully treated with gabapentin
    A Saverino
    Department of Neurological Sciences and Vision, University of Genoa, Genoa, Italy
    Mov Disord 16:967-8. 2001
    ..The patient reached the full dose of 1,200 mg/day of gabapentin without side effects and showed a significant therapy-related improvement of tremor and disability, as judged by the Fahn Tolosa Marin Rating Scale...
  13. ncbi Activity, tolerability and efficacy of levetiracetam on cerebellar symptoms in multiple sclerosis patients: a pilot kinematic study
    C Solaro
    Center of Bioengineering, Hospital La Colletta, Arenzano, Italy
    Eur J Neurol 15:619-26. 2008
    ....
  14. ncbi The 14-3-3 protein in multiple sclerosis: a marker of disease severity
    M Colucci
    Department of Neuroscience, Ophthalmology and Genetic and Center of Excellence for Biomedical Research, University of Genova, Genova, Italy
    Mult Scler 10:477-81. 2004
    ..CONCLUSIONS: The immunoblot analysis of 14-3-3 protein in the CSF could be a useful marker to identify a subgroup of DD patients with high risk of developing severe disability...
  15. ncbi Effect of glatiramer acetate on MS lesions enhancing at different gadolinium doses
    M Rovaris
    Neuroimaging Research Unit, Department of Neuroscience, Scientific Institute and University Ospedale San Raffaele, Milan, Italy
    Neurology 59:1429-32. 2002
    ..GA is effective in reducing MS activity, independent of the severity of the MRI-detectable inflammatory process...
  16. ncbi Autologous stem cell transplantation for severe autoimmune diseases: a 10-year experience
    F Gualandi
    Division of Hematology and Stem Cell Transplantation Center, Azienda Ospedaliera Universitaria S Martino, Italy
    Ann N Y Acad Sci 1110:455-64. 2007
    ..The mechanism of action of this intervention remains not completely understood, as briefly discussed here...